Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
Intranet Vendors: The 2026 Complete Guide
Standard intranet platforms cost between $5 and $50 per user per month. Applied across a global enterprise with tens of thousands of employees, that per-seat licensing represents a substantial and…
Healthcare Staff Portal: The 2026 Complete Guide
Replacing a single bedside registered nurse costs an average of $52,000. A hospital losing nurses at even a modest rate can lose millions each year to preventable attrition.While leaders often point…
E-HR Self-Service Portal: The 2026 Complete Guide
HR professionals still spend up to 40 percent of their working week answering routine inquiries and chasing compliance documents. That figure exists despite years of investment in self-service…
Corporate Intranet Portal: The 2026 Complete Guide
Only 13 percent of employees use their company's corporate intranet portal on a daily basis. Nearly a third of the workforce never logs in at all.Organizations have spent millions implementing…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
